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Abstract 
Various ecological studies report a reduction in cardiovascular disease mortality risk with increasing magnesium 
levels in drinking water. Most of the studies done in this field were epidemiologic studies.The aim of the present 
study was to examine whether magnesium addition to drinking water can affect risks of cardiac disease. The 
study included five groups of male albino rats. The rats received either tap water or water containing 5, 10, 20 g 
of magnesium sulfate per liter. During the whole experiment, all the groups received hypercholesterolemic diet 
except for the normal control which received normal basal diet. At the end of the experiment, blood was drawn 
for the determination of plasma magnesium, lipid profile and liver function. In addition, the extent of obesity 
was determined using the body mass index (BMI). In all groups magnesium addition was associated with higher 
levels of plasma magnesium. The blood analysis showed a significant decrease in serum total cholesterol, 
triglycerides, LDL- cholesterol and VLDL- cholesterol, while there was a significant increase in HDL- 
cholesterol in groups received magnesium sulfate in drinking water, compared with the hypercholesterolemic 
group received tap water. GOT, GPT and ALP followed the same trend. The addition of MgSO4 to the drinking 
water results in significant decrease in BMI of the magnesium treated groups relative to the 
hypercholesterolemic control. These results showed that high magnesium concentration in drinking water is 
capable of decreasing some cardiac disease risk factors in male albino rats.  
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1. Introduction 
Water is essential for life and the consideration of the characteristics of water as determinants of disease risk is 
turning into a critical issue. Water hardness is among these characteristics. It is defined as the measure of the 
concentration of calcium and magnesium ions in water. 
The bioavailability of Ca and Mg is accounted for to be higher from drinking water than from food 
(Couzy et al., 1995; Durlach et al., 1985). This is because Ca and Mg are normally present in water as free ions 
so, they are more readily absorbed compared to food, where they are usually bound to other substances (WHO, 
2005). 
The absorbability of Mg from water is higher by 30 % compared to dietary magnesium (Marx and 
Neutra, 1997).  
Therefore, not to remove hardness components (Ca & Mg) from drinking water or in certain 
circumstances increasing the magnesium and / or calcium intake from water may be of great importance 
especially for populations with an inadequate dietary intake of these elements(WHO, 2009). 
Many ecological investigations report a decrease in cardiovascular disease (CVD) mortality risk with 
increasing magnesium concentrations in drinking water and the evidence has accumulated that it is the main 
beneficial agent involved while the effect of calcium against CVD is only supportive. (Eisenberg, 1992). 
Cardiovascular disease (CVD) is a class of disease that involves the heart or blood vessels (Mendis et 
al., 2011).  
Many important cardiovascular risk factors can be modified by changing lifestyle, social change, drug 
treatment and prevention of hypertension, hyperlipidemia, and diabetes mellitus. (Micha et al., 2012).  
The diet rich in cholesterol is a main contributor to unbalanced lipid metabolism and is associated with 
an increase in coronary heart disease occurrence. (Libby, 2008). 
It was demonstrated by some studies that decreasing plasma total cholesterol, low- density lipoprotein 
cholesterol and increasing high-density lipoprotein cholesterol are of great benefit in preventing the risk of 
cardiovascular disease (Agbedana and Akanji, 1988).  
The aim of the present study is to assess the interrelationship between high magnesium concentration 
in drinking water and some risks of cardiac disease. 
 
2. Materials and Methods 
2.1 Animals and diet 
The animal protocol was designed to minimize pain or discomfort to the animals. 
Thirty adult male albino rats weighed 120 -130 g were used in the present experiment. The rats were 
housed under controlled light and temperature conditions (12 hours light: dark cycle, 22-23°C) for two weeks. 
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The animals were kept in the animal house of Regional Center for Food and Feed in the agricultural research 
center, Giza, Egypt. 
During this period, the normal diet (basal diet) as shown in table (1) and tap water were supplied ad 
lipitum. Each rat was weighed every week and the water intake was also recorded. 
Table (1): The composition of the basal diet (Campbell, 1961). 
Content % 
Casein 20 
Corn oil 10 
Salt mixture 4 
Vitamins mixture 1 
Cellulose 5 
starch 60 
Rats were divided into five groups each had 6 rats. The first group was fed on the basal diet and tap 
water and was considered as normal control (NC). 
The other rats (24 rats) were fed on hypercholesterolemic diet for 12 weeks (10% sheep tail fat + 1 % 
pure cholesterol + 0.25 % bile salt). 
They were divided into four groups. 
The first group (6 rats) was fed on hypercholesterolemic diet + tap water and was considered as 
hypercholesterolemic control (HC).  
The second group (6 rats) was fed on hypercholesterolemic diet + 5 g / L MgSO4 added to tap water. 
The third group (6 rats) was fed on hypercholesterolemic diet + 10 g / L MgSO4 added to tap water. 
The fourth group (6 rats) was fed on hypercholesterolemic diet + 20 g / L MgSO4 added to tap water. 
This hypercholesterolemic diet was shown to induce hypercholesterolemia in rats within three weeks. 
 
2.2 Blood sampling 
At the end of the experiment, blood samples were collected from each rat from the trirorbital venous plexus of 
the rat eye by capillary tube after an overnight fast, the blood samples were collected in dry tubes which were put 
in water bath at 37°c for 15 minutes, then centrifuged at 5000 r.p.m for 6 minutes and the colorless upper layers| 
(haemolysis – free serum) were carefully separated and transferred into sterilized test tubes for the analysis of 
total cholesterol, HDL- cholesterol, LDL- cholesterol, VLDL- cholesterol, triglycerides, as well as GOT, GPT, 
alkaline phosphatase activity (ALP) and serum magnesium. 
Spectrophotometer of Microlab 200, Merck was used in all biochemical analysis and the reagents and 
the standards were ready to use. 
 
2.3 Obesity assessment using the Body mass index 
The body weight and body length were used to determine the Body mass index (BMI) (Novelli et al., 2007).  
Body mass index (BMI) = body weight (g) / length2 (cm2). 
Body length (nose-to-anus or nose – anus length) was determined in all rats. The measurement was 
made in anaesthetized rats. 
 
2.4 Statistical analysis of the data 
Data were subjected to statistical analysis using the analysis of variance method and the means of treatments 
were compared by using the least significant difference (L.S.D) at 0.05 level of probability according to Duncan 
(1955) Multiple Range Test. 
 
3. Results 
3.1 Obesity assessment using the Body Mass Index (BMI) 
The body mass index (BMI) of rats of the different groups was determined and the results are shown in Table (2). 
It could be observed that feeding hypercholesterolemic diet raised the final body weight significantly 
compared to the basal diet. The average final body weight of the hypercholesterolemic control was 391.70 g 
while that of the normal control was 285.30g. 
The calculation of the body mass index was done by dividing the final body weight in grams by the square of the 
final body length in cm. 
The obtained results illustrated that the average gain in body weight at the end of the experimental 
period for normal control was 160.50g. The same table presents the result of the hypercholesterolemic control 
which showed that the average body weight gain was 265.67 g. So, there is a significant increase in body weight 
gain compared to the normal control. 
On the other hand, gains of the weight in the 5, 10 and 20 g/L MgSO4 treated groups were significantly 
lower when compared to the hypercholesterolemic group. They were 212.25, 201.42 and 174.10g respectively. 
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The same table shows that the body mass index (BMI) of the hypercholesterolemic control was 
significantly higher than that of the normal control. They were 0.72 and 0.52 g/cm2 respectively. 
The addition of MgSO4 to the drinking water results in significant decrease in BMI of the magnesium 
treated groups relative to the hypercholesterolemic group. 
It is obvious that the 20 g/L MgSO4 treated group showed the lowest BMI value in the magnesium 
treated groups. Its value was very close to the value of normal group. 
Table (2): Calculation of the body mass index (BMI): 
Treatments Initial body 
weight 
(g) 
Final body 
weight 
(g) 
Body weight 
gain 
(g) 
Final body 
length 
(cm) 
Body mass 
index (BMI) 
(g/cm2) 
Normal control 
(NC) 
a 
126.70 ± 1.09 
c 
285.30 ± 4.76 
c 
160.50 ± 4.12 
a 
23.60 ± 0.24 
c 
0.52 ± 0.01 
Hypercholesterolemic 
control 
(HC) 
a 
124.33 ± 1.30 
a 
391.70 ± 6.35 
a 
265.67 ± 5.69 
a 
23.33 ± 0.21 
a 
0.72 ± 0.004 
Treatment 1 
(5 g /l MgSO4) 
 
a 
126.08 ± 1.27 
b 
337.40 ± 0.88 
b 
212.25 ± 1.14 
a 
23.50 ± 0.22 
b 
0.61 ± 0.01 
Treatment 2 
(10 g /l MgSO4) 
 
a 
125.83 ± 1.20 
b 
326.70 ± 1.73 
b 
201.42 ± 2.34 
a 
23.50 ± 0.22 
b 
0.59 ± 0.01 
Treatment 3 
(20 g /l MgSO4) 
 
a 
124.40 ± 1.28 
c 
300.10 ± 3.61 
c 
174.10 ± 2.42 
a 
23.40 ± 0.24 
c 
0.55 ± 0.008 
L.S.D - 9.98 10.66 - 0.03 
1) Values are shown as average ± standard error (n=6). 
2) Different superscript letters in the same line indicate statistically significant difference for P < 0.05 (ANOVA). 
 
3.2 Effect of Magnesium added to drinking water on Lipogram profile 
Magnesium addition to the drinking water was associated with a significant reduction in plasma total cholesterol, 
triglycerides, LDL- cholesterol and VLDL- cholesterol levels while HDL- cholesterol was significantly 
increased, as judged from the pooled plasma samples in each group (Table 3). 
Table (3): Lipogram profile for the different groups: 
Treatments Total 
cholesterol 
mg/dl 
Triglycerides 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
VLDL 
mg/dl 
Normal control 
(NC) 
e 
75.57 ± 3.53 
d 
79.13 ± 3.90 
ab 
53.00 ± 2.35 
e 
6.74 ± 0.78 
d 
15.82 ± 0.78 
Hypercholesterolemic 
control 
(HC) 
a 
235.68 ± 12.9 
a 
158.61 ± 8.58 
b 
40.67 ± 3.40 
a 
163.29 ± 8.80 
a 
31.72 ± 1.72 
Treatment 1 
(5 g /l MgSO4) 
 
b 
191.13 ± 4.79 
b 
122.30 ± 2.79 
a 
59.33 ±4.88 
b 
107.34 ± 7.10 
b 
24.46 ± 0.55 
Treatment 2 
(10 g /l MgSO4) 
 
c 
154.26 ± 2.60 
bc 
107.05 ± 2.10 
a 
67.17 ± 3.40 
c 
65.69 ± 2.9 
bc 
21.41 ± 0.42 
Treatment 3 
(20 g /l MgSO4) 
 
d 
132.62 ± 3.37 
cd 
93.80 ± 1.03 
a 
68.80 ± 2.65 
d 
45.06 ± 1.39 
cd 
18.76 ± 0.20 
L.S.D 20.97 14.20 10.75 16.96 2.84 
1) Values are shown as average ± standard error (n=6).  
(2) Different superscript letters in the same line indicate statistically significant difference for P < 0.05 
(ANOVA). 
 
3.3 Effect of Magnesium added to drinking water on Liver function 
The average activity of GOT, GPT and ALP in serum are shown in table (4 ) and they were about 69.00, 34.80 
and 123.020 U/L for normal control while for hypercholesterolemic control were 107.17, 86.67 and 354.17 U/L 
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respectively. The results show significant increase in the values of GOT, GPT and ALP activities in 
hypercholesterolemic control relative to normal control. For MgSO4 treated groups the values were significantly 
lower when compared to the hypercholesterolemic control. 
Table (4): GOT, GPT and ALP activity for the different groups: 
Treatments GOT 
(U / I) 
GPT 
(U / I) 
Alkaline 
phosphatase 
(U / I) 
Normal control 
(NC) 
d 
69.00 ± 3.69 
e 
34.80 ± 1.85 
e 
123.20 ± 7.55 
Hypercholesterolemic 
control 
(HC) 
a 
107.17 ± 0.79 
a 
86.67 ± 4.20 
a 
354.17 ± 15.0 
Treatment 1 
(5 g /l MgSO4) 
ab 
100.83 ± 2.18 
b 
69.67 ± 1.52 
b 
269.17 ± 9.95 
Treatment 2 
(10 g /l MgSO4) 
bc 
92.50 ± 2.36 
c 
53.17 ± 2.83 
c 
217.33 ± 6.16 
Treatment 3 
(20 g /l MgSO4) 
c 
88.20 ± 4.53 
d 
43.00 ± 0.70 
d 
175.00 ± 8.22 
L.S.D 8.39 7.99 30.48 
1) Values are shown as average ± standard error (n=6).  
(2) Different superscript letters in the same line indicate statistically significant difference for P < 0.05 
(ANOVA). 
 
3.4 Effect of Magnesium added to drinking water on Serum magnesium 
The data in Table (5) revealed that there was no change in serum magnesium of the normal and 
hypercholesterolemic control. They were 2.72 and 2.77 mg/dl respectively. This is because both groups were 
drinking tap water through the whole experimental period. 
The values of serum magnesium in the magnesium treated groups increased significantly relative to the 
two control groups. The results were 3.75, 3.84 and 5.23 respectively. It was noticed that the maximum increase 
was in the 20 g/L MgSO4 treated group. 
 
3.5 Calculation of the exact dose of magnesium that each rat was consuming daily 
Both of the normal and hypercholesterolemic controls were consuming about 0.0005 g Mg / 24 hour. The three 
magnesium treated groups was consuming more magnesium daily. The increase in magnesium consumption was 
significantly higher than that of the normal and hypercholesterolemic control. 
Each rat in the 5, 10 and 20 g/L MgSO4 treated groups was consuming about 0.025, 0.055 and 0.152 g 
Mg / 24 h respectively. 
Table (5): Serum magnesium concentration of the different groups 
Treatments Magnesium 
(mg / dl) 
Normal control 
(NC) 
c 
2.72 ± 0.14 
Hypercholesterolemic 
control 
(HC) 
c 
2.77 ± 0.07 
Treatment 1 
(5 g /l MgSO4) 
b 
3.75 ± 0.24 
Treatment 2 
(10 g /l MgSO4) 
b 
3.84 ± 0.22 
Treatment 3 
(20 g /l MgSO4) 
a 
5.23 ± 0.24 
L.S.D 0.60 
1) Values are shown as average ± standard error (n=6).  
(2) Different superscript letters in the same line indicate statistically significant difference for P < 0.05 
(ANOVA). 
 
4. Discussion 
The present study shows that magnesium addition to drinking water induces beneficial protective effects against 
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cardiac diseases in male albino rats fed high fat diet. The lipogram profile showed significant reductions in 
cholesterol, triglyceride, LDL- cholesterol and VLDL- cholesterol levels as well as significant increase in HDL-
cholesterol in magnesium treated groups compared to the hypercholesterolemic group. The average total 
cholesterol of the hypercholesterolemic control was significantly higher than the normal control. Their values 
were 235.7 mg/dl and 75.6 mg/dl respectively. The total cholesterol of the magnesium treated groups 5, 10, 20 
g/L MgSO4 were significantly lower than that of the hypercholesterolemic control. They were 191.13, 154.26 
and 132.6 mg/dl respectively. 
It is clear that, the addition of MgSO4 to the drinking water cause more resistance to the elevation of 
serum total cholesterol. 
It was observed that the prevention of the elevation in the serum total cholesterol increase with the 
increase in MgSO4 concentration in water. 
As shown in Table (3), the average of triglycerides in the normal and hypercholesterolemic controls 
were 79.13 and 158.61 mg/dl respectively. 
Serum triglycerides levels for the magnesium treated groups 5, 10, 20 g/L MgSO4 were significantly 
lower than the hypercholesterolemic control. They were 122.30, 107.05 and 93.80 mg/dl respectively. It was 
noticed that the decrease in serum triglycerides level caused by the addition of 20 g/ L MgSO4 was not 
significantly different than that caused by the addition of 10 g/L MgSO4 . 
The elevation of serum LDL-Cholesterol is associated with increased risk of for coronary heart disease 
(CHD), it removes cholesterol from liver to other tissues.  
The serum LDL-cholesterol in the normal control was 6.74 mg/dl while in the hypercholesterolemic 
control was 163.29 mg/ dl. The concentrations of the LDL-cholesterol for the other three groups 5, 10 and 20 g/L 
MgSO4, were 107.34, 65.69 and 45.06 mg/dl respectively.  
It was observed that the increase in MgSO4 concentration in water caused significant resistance to the 
elevation in LDL-cholesterol levels relative to the hypercholesterolemic control. 
HDL- cholesterol has a protective effect impeding plaque formation and shows an inverse relationship 
to chronic heart disease (CHD) prevalence. In fact, low HDL- cholesterol values constitute an independent CHD 
risk factor. 
The data show that, the average HDL-cholesterol for normal control was 53.00 mg/dl but it was 
significantly lower in hypercholesterolemic control 40.67 mg/dl. 
The consumption of MgSO4 in drinking water caused significant elevation of the HDL- cholesterol 
levels relative to the hypercholesterolemic control. 
The Values of the HDL- cholesterol in the 5, 10 and 20g/L MgSO4 treated groups were 59.33, 67.17 
and 68.80 mg/dl, respectively. There was no significant difference in the increase in HDL- cholesterol levels 
among the three MgSO4 treatments. 
The average of serum VLDL-cholesterol for normal control was 15.82 mg/dl and was 31.72 mg/dl for 
hypercholesterolemic control. 
The three MgSO4 treated groups 5, 10 and 20g/L were significantly lower in serum VLDL-cholesterol 
relative to the hypercholesterolemic control. The VLDL-Cholesterol values of them were 24.46, 21.41 and 18.76 
mg/dl respectively. 
These results on the lipid profile are in agreement with other studies on the effect of magnesium on 
serum lipid fractions. 
Altura et al., 1990, emphasized that magnesium is highly effective in decreasing serum lipid fractions 
and in preventing the atherogenic process in rabbits. Also the study done by Olatunji and Soladoye 2007, who 
suggested that diet rich in magnesium could exert cardioprotective effect by reducing total cholesterol, 
triglycerides and ameliorated HDL-cholesterol, and Yaniv et al., 1999, who confirm that magnesium fortification 
of drinking water is capable of inhibiting athrogenisis in male LDL-receptor deficient mice. 
The liver function tests showed significant reductions in GOT, GPT and ALP levels in the magnesium 
treated groups which indicate the positive health impact of magnesium addition to water on liver. Elevated serum 
activity of these enzymes has been known to be indicators of risk of cardiovascular disease. The average activity 
of GOT, GPT and ALP in serum were about 69.00, 34.80 and 123.020 U/L for normal control while for 
hypercholesterolemic control were 107.17, 86.67 and 354.17 U/L respectively. 
The results show significant increase in the values of GOT, GPT and ALP activities in 
hypercholesterolemic control relative to normal control. 
For MgSO4 treated groups the values were significantly lower when compared to the 
hypercholesterolemic control. 
The results show that the GOT values of the 5, 10 and 20g/L MgSO4 treated groups were 100.83, 
92.50 and 88.20 U/L .There was only a slight difference between treatment 2 and 3. 
The GPT values of the 5, 10 and 20 g/L MgSO4 treated groups were 69.67, 53.17 and 43.00 U/L 
respectively. 
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The values of the ALP activity for the 5, 10 and 20 g/L MgSO4 treated groups were 269.17, 217.33 
and 175.00 U/L respectively. 
All groups show a significant decrease when compared to the hypercholesterolemic control. 
The body weight and body length were used to determine the Body mass index (BMI). There was a 
significant decrease in BMI of the magnesium treated groups relative to the hypercholesterolemic control.  
The administration of magnesium in water also led to a significant increase in plasma magnesium 
concentrations.  The values of serum magnesium in the magnesium treated groups increased significantly 
relative to the two control groups and reached its maximum in the 20 g/L MgSO4 treated group. 
Most of the results obtained in this study were dose dependent.  
The mechanism by which magnesium affects heart diseases risks may include effects on enzymes and/ 
or hormones.  
The results obtained from this study would provide information that could guide medical 
recommendations regarding the addition of Mg to water (Mg fortification of water) or bottled beverages.   
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